methyl 4-oxo-3,4-dihydroquinazoline-7-carboxylate CAS: 313535-84-1

Methyl 4-oxo-3,4-dihydroquinazoline-7-carboxylate ua lub luag haujlwm tseem ceeb hauv kev tsim cov tshuaj, ua lub hauv paus tseem ceeb rau ntau yam tshuaj bioactive. Nws cov quinazoline scaffold yog ib qho qauv tsim uas pom muaj nyob rau hauv ntau yam tshuaj, suav nrog cov neeg sawv cev tiv thaiv kab mob qog noj ntshav, cov tshuaj antihistamines, thiab kinase inhibitors. Los ntawm kev siv qhov ua tau ntau yam ntawm cov tshuaj no, cov kws tshuaj tuaj yeem nkag mus rau ntau txoj hauv kev tsim cov tshuaj tshiab nrog cov txiaj ntsig kho mob. Ntxiv mus, nws txoj kev koom ua ke rau hauv kev tshawb nrhiav tshuaj ua rau muaj kev hloov pauv ntawm quinazoline framework los tsim cov derivatives nrog cov khoom pharmacological zoo tshaj plaws, xws li kev txhim kho potency thiab kev xaiv. Ntxiv mus, cov tshuaj no yog siv rau hauv kev tshawb fawb kev kawm thiab kev teeb tsa kev lag luam los tshawb nrhiav cov tshuaj tshiab nrog cov ntaub ntawv pharmacological cog lus. Kev ntseeg tau thiab kev sib xws ntawm methyl 4-oxo-3,4-dihydroquinazoline-7-carboxylate ua rau nws yog ib qho cuab yeej tseem ceeb hauv kev lag luam tshuaj, pab txhawb kev tsim cov tshuaj molecules nyuaj thaum ua kom ntseeg tau tias cov txiaj ntsig rov ua dua. Ua ib qho tseem ceeb hauv kev siv tshuaj lom neeg, nws ua rau cov kws tshawb fawb nthuav dav qhov chaw tshuaj lom neeg ntawm cov neeg muaj peev xwm siv tshuaj thiab txhawb kev tsim cov kev kho mob tshiab rau ntau yam mob.